DI Mobile Menu

Search form


New brachy product begins use

New brachy product begins use

New brachy product begins use
The first patient has been treated with the Flexitron brachytherapy product, available from Nucletron and its developer, Isodose Control. The 40-channel afterloader was applied in the treatment of breast cancer at the Cancer Specialists of Oklahoma in Oklahoma City. Flexitron was recently integrated into Nucletron's offering of high dose rate brachytherapy afterloaders, applicators, and treatment planning solutions Sept. 1 when Nucletron and Isodose Control forged a partnership to serve the global brachytherapy marketplace. Nucletron is framing the newly introduced product as the next generation of afterloading platforms for cancer treatment. The brachytherapy product employs a 40-channel radiation delivery system with DICOM compatibility and includes dual radiation source capabilities and multiple isotope compatibility.


Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.